{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T02:50:36Z","timestamp":1760151036805,"version":"build-2065373602"},"reference-count":39,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T00:00:00Z","timestamp":1644278400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vision"],"abstract":"<jats:p>Purpose: The present study evaluates the differences in the prevalence of the signs and symptoms of ocular surface disease (OSD) in patients with PEX glaucoma (PEXG), compared to other glaucoma types (non-PEXG). Methods: Patients with non-PEXG and PEXG were prospectively examined for the presence and severity of OSD signs and questioned for symptoms using the OSDI (ocular surface disease index) questionnaire. Results: 116 patients were prospectively enrolled (58 non-PEXG and 58 PEXG). PEXG subjects who were older, had lower central corneal thickness (CCT) values, at a more advanced glaucoma stage and required more IOP lowering drops. OSD signs were prevalent in both groups: conjunctival hyperemia (74.5% non-PEXG vs. 94.8% PEXG), eyelid redness (70.7% vs. 96.6%), conjunctival (74.1% vs. 93.1%) and corneal fluorescein staining (81% vs. 93.1%) and abnormal TFBUT (82.8% vs. 87.9%). When adjusted for potential confounders, (older age, thinner CCT, more advanced glaucoma in PEXG) eyelid redness remained the only parameter significantly associated with PEXG, being 11 times more likely to occur in this group (p = 0.037). Conclusion: Subjects with PEXG presented a higher frequency of signs of OSD compared to other glaucoma types. When accounting for confounding factors, the only difference between the groups was the significantly higher presence (11 times more likely) of eyelid redness in PEXG, suggesting, in addition to glaucoma treatment, the impact of PEX on ocular surface integrity.<\/jats:p>","DOI":"10.3390\/vision6010011","type":"journal-article","created":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T23:42:20Z","timestamp":1644363740000},"page":"11","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Ocular Surface Disease Signs and Symptoms in Patients with Pseudoexfoliative Glaucoma: A Case\u2014Control Study"],"prefix":"10.3390","volume":"6","author":[{"given":"Maria","family":"Dermenoudi","sequence":"first","affiliation":[{"name":"Health Center of Neapolis, 56727 Thessaloniki, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Artemis","family":"Matsou","sequence":"additional","affiliation":[{"name":"Ophthalmology Department, Queen Victoria Hospital NHS Foundation Trust, East Grinstead RH19 3DZ, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Keskini","sequence":"additional","affiliation":[{"name":"1st Department of Ophthalmology, Aristotle University of Thessaloniki, 54621 Thessaloniki, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleftherios","family":"Anastasopoulos","sequence":"additional","affiliation":[{"name":"2nd Department of Ophthalmology, Aristotle University of Thessaloniki, 56403 Thessaloniki, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,2,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/00061198-199400320-00018","article-title":"Exfoliation syndrome\u2014The most common identifiable cause of open-angle glaucoma","volume":"3","author":"Ritch","year":"1994","journal-title":"J. Glaucoma"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.ajo.2006.01.047","article-title":"Ocular and systemic pseudoexfoliation syndrome","volume":"141","author":"Naumann","year":"2006","journal-title":"Am. J. Ophthalmol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1034\/j.1600-0420.1999.770409.x","article-title":"Evaluation of tear secretion and tear film stability in pseudoexfoliation syndrome","volume":"77","author":"Kozobolis","year":"1999","journal-title":"Acta Ophthalmol. Scand."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1755-3768.1973.tb06018.x","article-title":"On the occurrence of pseudoexfoliation material in extrabulbar tissue from patients with pseudoexfoliation syndrome of the eye","volume":"51","author":"Ringvold","year":"1973","journal-title":"Acta Ophthalmol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1755-3768.1991.tb02009.x","article-title":"Occurrence of pseudoexfoliative material in parabulbar structures in pseudoexfoliation syndrome","volume":"69","author":"Kuchle","year":"1991","journal-title":"Acta Ophthalmol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1442-9071.2006.01168.x","article-title":"Conjunctival impression cytology in pseudoexfoliative glaucoma and pseudoexfoliation syndrome","volume":"34","author":"Erdogan","year":"2006","journal-title":"Clin. Exp. Ophthalmol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1542-0124(12)70081-2","article-title":"The definition and classification of dry eye disease: Report of the Definition and Classification Subcommittee of the International Dry Eye Workshop","volume":"5","author":"Lemp","year":"2007","journal-title":"Ocul. Surf."},{"key":"ref_8","first-page":"3","article-title":"Fluorescein angiographic studies of the peripapillary and perilimbal regions in simple, capsular and low-tension glaucoma","volume":"111","author":"Laatikainen","year":"1971","journal-title":"Acta Ophthalmol. Suppl."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1136\/bjo.86.4.418","article-title":"Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication","volume":"86","author":"Pisella","year":"2002","journal-title":"Br. J. Ophthalmol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1097\/ICO.0b013e31823f8e7d","article-title":"Comparison of the long-term effects of various topical antiglaucoma medications on meibomian glands","volume":"31","author":"Arita","year":"2012","journal-title":"Cornea"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jtos.2018.03.002","article-title":"Exploring topical anti-glaucoma medication effects on the ocular surface in the context of the current understanding of dry eye","volume":"16","author":"Wong","year":"2018","journal-title":"Ocul. Surf."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1007\/s12325-018-0699-8","article-title":"Prospective, randomized, single masked, parallel study exploring the effects of a preservative-free ophthalmic solution containing hyaluronic acid 0.4% and taurine 0.5% on the ocular surface of glaucoma patients under multiple long-term topical hypotensive therapy","volume":"35","author":"Roberti","year":"2018","journal-title":"Adv. Ther."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/00003226-200310000-00008","article-title":"Grading of Corneal and Conjunctival Staining in the Context of Other Dry Eye Tests","volume":"22","author":"Bron","year":"2003","journal-title":"Cornea"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1046\/j.1475-1313.2001.00575.x","article-title":"Grading scales for contact lens complications","volume":"18","author":"Efron","year":"1998","journal-title":"Ophthalmic Physiol. Opt."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/archopht.118.5.615","article-title":"Reliability and Validity of the Ocular Surface Disease Index","volume":"118","author":"Schiffman","year":"2000","journal-title":"Arch. Ophthalmol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1177\/112067210901900409","article-title":"Dry eye syndrome-related quality of life in glaucoma patients","volume":"19","author":"Rossi","year":"2009","journal-title":"Eur. J. Ophthalmol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"694","DOI":"10.5301\/ejo.5000977","article-title":"Ocular surface disease in patients under topical treatment for glaucoma","volume":"27","author":"Polo","year":"2017","journal-title":"Eur. J. Ophthalmol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1097\/IJG.0000000000001007","article-title":"Evaluation of Ocular Surface Disease in Patients with Glaucoma: Clinical Parameters, Self-report Assessment, and Keratograph Analysis","volume":"27","author":"Portela","year":"2018","journal-title":"J. Glaucoma"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1600-0420.2007.00882.x","article-title":"Use of eyedrops in glaucoma: How can we help to reduce non-compliance?","volume":"85","author":"Chawla","year":"2007","journal-title":"Acta Ophthalmol. Scand."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/ICU.0b013e32835c8aba","article-title":"Glaucoma therapy and ocular surface disease: Current literature and recommendations","volume":"24","author":"Anwar","year":"2013","journal-title":"Curr. Opin. Ophthalmol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/j.ophtha.2013.01.020","article-title":"Pseudoexfoliation: Normative data and associations: The Beijing eye study","volume":"120","author":"You","year":"2013","journal-title":"Ophthalmology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/ICU.0b013e32835d5d11","article-title":"Exfoliation syndrome: New genetic and pathophysiologic insights","volume":"24","author":"Sein","year":"2013","journal-title":"Curr. Opin. Ophthalmol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3928\/15428877-20080101-05","article-title":"Comparative results of central corneal thickness measurements in primary open-angle glaucoma, pseudoexfoliation glaucoma, and ocular hypertension","volume":"39","author":"Gorezis","year":"2008","journal-title":"Ophthalmic Surg. Lasers Imaging Retin."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1016\/j.ophtha.2004.06.013","article-title":"Central corneal thickness of Caucasians, Chinese, Hispanics, Filipinos, African Americans, and Japanese in a glaucoma clinic","volume":"111","author":"Aghaian","year":"2004","journal-title":"Ophthalmology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0021-5155(03)00022-4","article-title":"Morphological study of corneal endothelium and corneal thickness in pseudoexfoliation syndrome","volume":"47","author":"Inoue","year":"2003","journal-title":"Jpn. J. Ophthalmol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/00061198-200604000-00003","article-title":"Correlation between intraocular pressure, central corneal thickness, stage of glaucoma, and demographic patient data: Prospective analysis of biophysical parameters in tertiary glaucoma practice populations","volume":"15","author":"Kniestedt","year":"2006","journal-title":"J. Glaucoma"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/IJG.0b013e3181f7afb8","article-title":"Central Corneal Thickness and Corneal Curvature in Pseudoexfoliation Syndrome with and Without Glaucoma","volume":"20","author":"Ozcura","year":"2011","journal-title":"J. Glaucoma"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/IJG.0000000000000110","article-title":"In Vivo Confocal Microscopic Evaluation of Corneas in Patients with Exfoliation Syndrome","volume":"25","author":"Kocabeyoglu","year":"2016","journal-title":"J. Glaucoma"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/s41433-018-0033-3","article-title":"The thick and thin of the central corneal thickness in glaucoma","volume":"32","author":"Belovay","year":"2018","journal-title":"Eye"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/j.1600-0420.2007.01051.x","article-title":"Pseudoexfoliation in the reykjavik eye study: Prevalence and related ophthalmological variables","volume":"85","author":"Arnarsson","year":"2007","journal-title":"Acta Ophthalmol. Scand."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"677","DOI":"10.3129\/i07-145","article-title":"Corneal curvature and central corneal thickness in eyes with pseudoexfoliation syndrome","volume":"42","author":"Hepsen","year":"2007","journal-title":"Can. J. Ophthalmol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1442-9071.2010.02313.x","article-title":"Characteristics of the corneal endothelium and pseudoexfoliation syndrome in patients with senile cataract","volume":"38","author":"Quiroga","year":"2010","journal-title":"Clin. Exp. Ophthalmol."},{"key":"ref_33","unstructured":"Stamper, R.L., Lieberman, M.F., and Drake, M.V. (2009). Becker-Shaffer\u2019s Diagnosis and Therapy of the Glaucomas, Mosby. [8th ed.]."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/IJG.0b013e31821dac66","article-title":"Comparison of Visual Field Severity Classification Systems for Glaucoma","volume":"21","author":"Ng","year":"2012","journal-title":"J. Glaucoma"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e222","DOI":"10.1097\/OPX.0000000000000542","article-title":"Ocular surface disease in glaucoma: Effect of polypharmacy and preservatives","volume":"92","author":"Ramli","year":"2015","journal-title":"Optom. Vis. Sci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/IIO.0000000000000232","article-title":"Ocular surface disease in the glaucoma patient","volume":"58","author":"Banitt","year":"2018","journal-title":"Int. Ophthalmol. Clin."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1097\/ICO.0b013e3181c325b2","article-title":"Prevalence of Ocular Surface Complaints in Patients with Glaucoma Using Topical Intraocular Pressure-Lowering Medications","volume":"29","author":"Fechtner","year":"2010","journal-title":"Cornea"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/IJG.0b013e31815c5f4f","article-title":"Prevalence of Ocular Surface Disease in Glaucoma Patients","volume":"17","author":"Leung","year":"2008","journal-title":"J. Glaucoma"},{"key":"ref_39","first-page":"305","article-title":"The Effect of Pseudoexfoliation and Pseudoexfoliation Induced Dry Eye on Central Corneal Thickness","volume":"41","author":"Akdemir","year":"2016","journal-title":"Curr. Eye Res."}],"container-title":["Vision"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2411-5150\/6\/1\/11\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:16:26Z","timestamp":1760134586000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2411-5150\/6\/1\/11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,8]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,3]]}},"alternative-id":["vision6010011"],"URL":"https:\/\/doi.org\/10.3390\/vision6010011","relation":{},"ISSN":["2411-5150"],"issn-type":[{"type":"electronic","value":"2411-5150"}],"subject":[],"published":{"date-parts":[[2022,2,8]]}}}